Anti-IL-6 Receptor Tocilizumab in Refractory Graves' Orbitopathy: National Multicenter Observational Study of 48 Patients.

Graves’ disease Graves’ ophthalmopathy Tocilizumab corticoid-resistant extrathyroidal manifestations thyroid-associated ophthalmopathy

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
31 Aug 2020
Historique:
received: 21 06 2020
revised: 18 08 2020
accepted: 29 08 2020
entrez: 4 9 2020
pubmed: 4 9 2020
medline: 4 9 2020
Statut: epublish

Résumé

Graves' orbitopathy (GO) is the most common extrathyroidal manifestation of Graves' disease (GD). Our aim was to assess the efficacy and safety of Tocilizumab (TCZ) in GO refractory to conventional therapy. This was an open-label multicenter study of glucocorticoid-resistant GO treated with TCZ. The main outcomes were the best-corrected visual acuity (BVCA), Clinical Activity Score (CAS) and intraocular pressure (IOP). These outcome variables were assessed at baseline, 1st, 3rd, 6th and 12th month after TCZ therapy onset. The severity of GO was assessed according to the European Group on Graves' Orbitopathy (EUGOGO). We studied 48 (38 women and 10 men) patients (95 eyes); mean age ± standard deviation 51 ± 11.8 years. Before TCZ and besides oral glucocorticoids, they had received IV methylprednisolone (

Identifiants

pubmed: 32878150
pii: jcm9092816
doi: 10.3390/jcm9092816
pmc: PMC7563792
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Endocr Metab Immune Disord Drug Targets. 2018;18(6):665-667
pubmed: 29962351
Semin Arthritis Rheum. 2015 Dec;45(3):361-8
pubmed: 26092330
J Clin Endocrinol Metab. 2015 Feb;100(2):422-31
pubmed: 25494967
Curr Opin Ophthalmol. 2018 Nov;29(6):528-534
pubmed: 30124533
Semin Arthritis Rheum. 2019 Aug;49(1):126-135
pubmed: 30655091
J Ophthalmol. 2017;2017:7298026
pubmed: 28785483
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 1999;5(2):85-93
pubmed: 12818091
Am J Ophthalmol. 2019 Apr;200:85-94
pubmed: 30660771
Ophthalmic Plast Reconstr Surg. 2014 Mar-Apr;30(2):162-7
pubmed: 24503568
Thyroid. 2019 Apr;29(4):557-562
pubmed: 30688164
Thyroid. 2008 Mar;18(3):333-46
pubmed: 18341379
Rheumatology (Oxford). 2018 May 1;57(5):856-864
pubmed: 29471416
Am J Ophthalmol. 2018 Nov;195:181-190
pubmed: 30081019
Lancet. 2013 May 4;381(9877):1541-50
pubmed: 23515142
Drugs. 2019 Feb;79(2):109-124
pubmed: 30659423
N Engl J Med. 2017 May 4;376(18):1748-1761
pubmed: 28467880
Ocul Immunol Inflamm. 2018;26(8):1166-1173
pubmed: 28628344
Am J Ophthalmol Case Rep. 2017 Jul 08;7:146-148
pubmed: 29260102
Horm Metab Res. 2018 Dec;50(12):871-886
pubmed: 30286486
Arthritis Care Res (Hoboken). 2017 Oct;69(10):1484-1494
pubmed: 28622454
Br J Clin Pharmacol. 2004 Jan;57(1):86-92
pubmed: 14678345
Endocr Res. 2012;37(2):89-95
pubmed: 22489922
J R Stat Soc Ser A Stat Soc. 2001 Apr 1;174(2):369-386
pubmed: 24926156
Int Ophthalmol Clin. 2018 Spring;58(2):137-179
pubmed: 29517649
J Clin Endocrinol Metab. 2015 Feb;100(2):432-41
pubmed: 25343233
Farm Hosp. 2014 Sep 16;38(5):448-50
pubmed: 25344141
Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):S34-S40
pubmed: 27054359
Klin Monbl Augenheilkd. 2017 Apr;234(4):567-570
pubmed: 28147401
Ann Endocrinol (Paris). 2018 Dec;79(6):656-664
pubmed: 30177259
Drugs. 2017 Nov;77(17):1865-1879
pubmed: 29094311
Front Biosci (Landmark Ed). 2019 Jan 1;24:35-47
pubmed: 30468646
Int Ophthalmol. 2018 Oct;38(5):2247-2255
pubmed: 28822031
J Ocul Pharmacol Ther. 2017 May;33(4):240-246
pubmed: 28355124
J Clin Endocrinol Metab. 1996 Aug;81(8):2976-9
pubmed: 8768861
Ophthalmology. 2018 Sep;125(9):1444-1451
pubmed: 29602570
Rev Med Interne. 2018 Sep;39(9):746-754
pubmed: 29398045
J Ophthalmol. 2015;2015:249125
pubmed: 26351570
Clin Endocrinol (Oxf). 1997 Jul;47(1):9-14
pubmed: 9302365
Arch Soc Esp Oftalmol. 2018 Aug;93(8):386-391
pubmed: 29937157
Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S54-7
pubmed: 25005576
Ocul Immunol Inflamm. 2020;28(2):281-284
pubmed: 30457413
Ophthalmic Plast Reconstr Surg. 2017 May/Jun;33(3):e55-e57
pubmed: 27281483
Semin Arthritis Rheum. 2016 Aug;46(1):95-101
pubmed: 27060872

Auteurs

Lara Sánchez-Bilbao (L)

Rheumatology, Ophthalmology and Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, 39008 Santander, Spain.

David Martínez-López (D)

Rheumatology, Ophthalmology and Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, 39008 Santander, Spain.

Marcelino Revenga (M)

Rheumatology and Ophthalmology, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.

Ángel López-Vázquez (Á)

Rheumatology and Ophthalmology, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.

Elia Valls-Pascual (E)

Rheumatology and Ophthalmology, Hospital Universitari Doctor Peset, 46017 Valencia, Spain.

Belén Atienza-Mateo (B)

Rheumatology, Ophthalmology and Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, 39008 Santander, Spain.

Beatriz Valls-Espinosa (B)

Rheumatology and Ophthalmology, Hospital Universitari Doctor Peset, 46017 Valencia, Spain.

Olga Maiz-Alonso (O)

Rheumatology and Ophthalmology, Hospital Universitario de Donosti, 20014 San Sebastián, Spain.

Ana Blanco (A)

Rheumatology and Ophthalmology, Hospital Universitario de Donosti, 20014 San Sebastián, Spain.

Ignacio Torre-Salaberri (I)

Rheumatology and Ophthalmology, Hospital Universitario de Basurto, 48013 Bilbao, Spain.

Verónica Rodríguez-Méndez (V)

Rheumatology and Ophthalmology, Hospital Universitario de Basurto, 48013 Bilbao, Spain.

Ángel García-Aparicio (Á)

Rheumatology, Hospital Virgen de la Salud, 45004 Toledo, Spain.

Raúl Veroz-González (R)

Rheumatology, Hospital de Mérida, 06800 Mérida, Spain.

Vega Jovaní (V)

Rheumatology, Hospital General Universitario de Alicante, 03010 Alicante, Spain.

Diana Peiteado (D)

Rheumatology and Ophthalmology, Hospital Universitario La Paz, 28046 Madrid, Spain.

Margarita Sánchez-Orgaz (M)

Rheumatology and Ophthalmology, Hospital Universitario La Paz, 28046 Madrid, Spain.

Eva Tomero (E)

Rheumatology, Hospital de La Princesa, IIS-Princesa, 28006 Madrid, Spain.

Francisco J Toyos-Sáenz de Miera (FJ)

Rheumatology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.

Valvanera Pinillos (V)

Rheumatology, Hospital San Pedro, 26006 Logroño, Spain.

Elena Aurrecoechea (E)

Rheumatology and Ophthalmology, Hospital Sierrallana, 39300 Torrelavega, Spain.

Ángel Mora (Á)

Rheumatology and Ophthalmology, Hospital Sierrallana, 39300 Torrelavega, Spain.

Arantxa Conesa (A)

Rheumatology, Hospital Clínico Universitario de Valencia, 46018 Valencia, Spain.

Manuel Fernández-Prada (M)

Rheumatology, Hospital Universitario de Guadalajara, 19002 Guadalajara, Spain.

Juan A Troyano (JA)

Ophthalmology, Hospital Universitario Clínico San Carlos, 28040 Madrid, Spain.

Vanesa Calvo-Río (V)

Rheumatology, Ophthalmology and Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, 39008 Santander, Spain.

Rosalía Demetrio-Pablo (R)

Rheumatology, Ophthalmology and Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, 39008 Santander, Spain.

Íñigo González-Mazón (Í)

Rheumatology, Ophthalmology and Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, 39008 Santander, Spain.

José L Hernández (JL)

Rheumatology, Ophthalmology and Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, 39008 Santander, Spain.

Santos Castañeda (S)

Rheumatology, Hospital de La Princesa, IIS-Princesa, 28006 Madrid, Spain.
Cátedra UAM-Roche, EPID-Future, Universidad Autónoma de Madrid (UAM), 28049 Madrid, Spain.

Miguel Á González-Gay (MÁ)

Rheumatology, Ophthalmology and Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, 39008 Santander, Spain.

Ricardo Blanco (R)

Rheumatology, Ophthalmology and Internal Medicine, Hospital Universitario Marqués de Valdecilla, IDIVAL, University of Cantabria, 39008 Santander, Spain.

Classifications MeSH